Kirby-Smith et al. (2023) [41] have recently reported a study on AV polysaccharides in microparticle formulations, which significantly improved nasal insulin delivery, used for the treatment of Alzheimer’s disease (AD) and diabetes mellitus (DM). Here, INS is linked to Alzheimer disease.